December 9, 2020 M&A, Partnerships Process Analytical Instr.

Sartorius acquires filtration expert WaterSep BioSeparations

Göttingen, December 9, 2020 Transaction provides a complementary fit with Sartorius’ separation portfolio, adding innovative crossflow filtration units for easy-to-use bioprocessing devices Technology is especially suited to gene and cell therapy applications, vaccine production and intensified bioprocessing  The life science company Sartorius today acquired U.S.‑based purification expert WaterSep BioSeparations LLC through its subgroup Sartorius Stedim Biotech.... Read more

December 9, 2020 M&A, Partnerships Process Analytical Instr. Product Launch

Activated Research Company Partners with Shimadzu Scientific Instruments to Offer Jetanizer

The world’s smallest methanizer now available for Shimadzu 2030 GCs Activated Research Company (ARC) is excited to announce that the Jetanizer is now available through Shimadzu Scientific Instruments (SSI) for Shimadzu GC-2030instruments. SSI will be offering the Jetanizer through its headquarters in Columbia, MD directly to end users in the US and to Shimadzu subsidiaries throughout... Read more

December 9, 2020 M&A, Partnerships Materials Analysis

Amphenol Corporation to Acquire MTS Systems

WALLINGFORD, Conn. & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Dec. 9, 2020– Amphenol Corporation (NYSE: APH) (“Amphenol”), a leading global provider of high-technology interconnect, antenna and sensor solutions, and MTS Systems Corporation (Nasdaq: MTSC) (“MTS”), a leading global supplier of advanced test systems, motion simulators and precision sensors, today announced that they have entered into a definitive agreement... Read more

December 9, 2020 Lab Top-10

Thermo Fisher Scientific Further Expands Global Footprint for Drug Product Development and Commercial Manufacturing

Thermo Fisher Scientific Further Expands Global Footprint for Drug Product Development and Commercial Manufacturing WALTHAM, Mass., Dec. 9, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies... Read more

December 9, 2020 M&A, Partnerships

Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials

Moderna’s vaccine triggers an antibody response to the SARS-CoV-2 spike protein The Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine trial participants and could help to establish correlation to protection from COVID-19 Emergency Use Authorisation by the US FDA for the Elecsys Ab test was granted on 25... Read more

December 8, 2020 Environ, Ag./Food & Bev Life Science Tools

Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing

SAN DIEGO & WELLESLEY, Mass.–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey experienced... Read more

December 8, 2020 Other Lab Products/Services Product Launch

eNUVIO is Launching the EB-Plate

The first completely reusable 3D cell culture microplate on the market Caption: The first completely reusable 3D cell culture microplate on the market. To download image, please click here. Montreal, Canada, December 8th 2020 – Life Science Newswire – eNUVIO announced the release of the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high-volumes of single-use... Read more

December 8, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay

December 8, 2020 at 10:17 AM EST CINCINNATI, Dec. 08, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has submitted its application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for the company’s SARS-CoV-2 molecular diagnostic test on the Revogene® platform. The... Read more

December 8, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

LGC’s Anti-SARS-CoV-2 controls kit now CE Marked

LGC is pleased to announce that the ACCURUN® Anti-SARS-CoV-2 Reference Material Kit is now CE marked for in vitro diagnostic use (CE-IVD). With this change in regulatory status, the new product name is ACCURUN Anti-SARS-CoV-2 Controls Kit. Bearing the CE mark and IVD symbol signifies that the ACCURUN Anti-SARS-CoV-2 Controls Kit meets extensive design control requirements. ACCURUN... Read more